| Outcome Measures: |
Primary: Change in liver stiffness, liver stiffness measurement performed by transient elastography, Baseline to Week 52|Frequency and severity of treatment-emergent adverse events (TEAEs) and treatment-emergent serious adverse events (TESAEs), Baseline to Week 52 | Secondary: Change in TG, HDL-C, LDL-C and non HDL-C levels, Baseline to Week 24 and Week 52|Change in serum ALT value, Baseline to Week 24 and Week 52|Change in serum AST value, Baseline to Week 24 and Week 52|Change in serum ALP value, Baseline to Week 24 and Week 52|Change in body weight, Baseline to Week 24 and Week 52|Change in BMI, Baseline to Week 24 and Week 52
|
| Locations: |
Gastroplus Digestive Disease Centre, Ahmedabad, India|Mission GastroHospital, Ahmedabad, India|Artemis Hospital, Gurgaon, India|Medanta- TheMedicity, Gurgaon, India|Malla ReddyNarayanaMultispecialtyHospital, Hyderabad, India|Osmania GeneralHospital, Hyderabad, India|Yashoda Hospitals, Hyderabad, India|CARE CHL -Hospitals (Unit ofConvenient HospitalLtd., Indore, India|S R Kalla MemorialGastro and GenralHospital, Jaipur, India|AIIMS, Khorda, India|Medanta Hospital, Lucknow, India|Dayanand MedicalCollege & Hospital, Ludhiāna, India|Neurociti Hospital, Ludhiāna, India|TNMC & BYL NairCh. Hospital, Mumbai, India|Shree Siddhivinayak Maternity & Nursing Home, Nashik, India|Sir GangaramHospital, New Delhi, India|Alchemist Hospital, Panchkula, India|Fortis Hospital, Rupnagar, India|BAPS Pramukh Swami Hospital, Sūrat, India
|
